ImportRefusal LogoImportRefusal

Alcon Laboratories Inc 6

⚠️ High Risk

FEI: 3005652917 • Fort Worth, TX • UNITED STATES

FEI

FEI Number

3005652917

📍

Location

Fort Worth, TX

🇺🇸
🏢

Address

International Import/Export Dept, 201 South Freeway Am-4, Fort Worth, TX, United States

High Risk

FDA Import Risk Assessment

52.4
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

6
Total Refusals
5
Unique Violations
10/27/2025
Latest Refusal
10/19/2022
Earliest Refusal

Score Breakdown

Violation Severity
61.8×40%
Refusal Volume
31.3×30%
Recency
81.7×20%
Frequency
19.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32803×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

5082×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1791×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

Refusal History

DateProductViolationsDivision
10/27/2025
86LPLLENSES, SOFT CONTACT, DAILY WEAR
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)
10/22/2024
86LPMLENSES, SOFT CONTACT, EXTENDED WEAR
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/18/2023
86MVNLENS, CONTACT (DISPOSABLE)
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)
8/25/2023
63HCL25POLYETHYLENE GLYCOL 3350/ELECTROLYTES (CARTHARTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/22/2023
60CDK46NAPHAZOLINE HCL (ADRENERGIC)
179AGR RX
Division of West Coast Imports (DWCI)
10/19/2022
86LPMLENSES, SOFT CONTACT, EXTENDED WEAR
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Alcon Laboratories Inc 6's FDA import refusal history?

Alcon Laboratories Inc 6 (FEI: 3005652917) has 6 FDA import refusal record(s) in our database, spanning from 10/19/2022 to 10/27/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Alcon Laboratories Inc 6's FEI number is 3005652917.

What types of violations has Alcon Laboratories Inc 6 received?

Alcon Laboratories Inc 6 has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Alcon Laboratories Inc 6 come from?

All FDA import refusal data for Alcon Laboratories Inc 6 is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.